These results provide evidence that TUDCA pretreatment inhibits Smad2/3-medited EMT and subsequent lung fibrosis partially through suppressing BLM-induced ER stress and oxidative stress. This evidence concerns the gene SMAD2 and pulmonary fibrosis.